Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Sarcopenia in Patients With Gastrointestinal Stromal Tumours
Authors not listed
CHU de Reims · 2014
Abstract
The treatment of advanced gastrointestinal stromal tumours (GIST) has shifted since the arrival of targeted therapies. Imatinib is an active multikinase inhibitor that mainly targets C-kit tyrosine-kinase receptors and the platelet-derived growth factor receptor. Imatinib use has been validated for adjuvant and palliative therapy settings. Imatinib is generally well-tolerated and known to improve performance status but up to 16% grades 3-4 toxicities, leading to at least 40% withdrawals, have been reported.
Recently, in oncology, sarcopenia was shown to be a predictor of severe toxicity patients included in phase 1 trials, suggesting that it should be considered an inclusion criterion for such studies. Sarcopenic patients had low performance status, shorter survival, more chemotherapy toxicities and post-operative infections, and longer post-operative hospitalization times. In addition, exposure to tyrosine-kinase inhibitors (e.g. sorafenib or sunitinib) has been associated with dose-limiting toxicity (DLT) in patients with renal cell or hepatocellular carcinomas.
Computed tomography (CT) scans acquired during routine care have been validated as an accurate and robust imaging technique to evaluate sarcopenia in cancer patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2014). Sarcopenia in Patients With Gastrointestinal Stromal Tumours. <em>CHU de Reims</em>. https://clinicaltrials.gov/study/NCT02877368
Vancouver
Anonymous. Sarcopenia in Patients With Gastrointestinal Stromal Tumours. CHU de Reims. 2014.
BibTeX
@misc{anon2014Sarcop,
title = {Sarcopenia in Patients With Gastrointestinal Stromal Tumours},
author = {Anonymous},
journal = {CHU de Reims},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Immunology 2020
Open access · CC-BY
Frailty in Rheumatic Diseases
DNA repair 2007
Preprint · OA
Changes in the level and distribution of Ku proteins during cellular senescence
Kölner Universitäts PublikationsServer (Universität zu Köln) 2014
Preprint
The Role of Endoplasmic Reticulum Protein Quality Control in Longevity
Dionyssiotis, Yannis, M.D. 2018
Open access · US-GOV
Sarcopenia and Diabetes Mellitus
Neuromolecular medicine 2026
Open access · OA
SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential.
Sports Medicine 2024
Open access · CC-BY